Q1 2017 XBiotech Inc Earnings Call
Conference Call XBiotech Inc
XBiotech Inc Conference call or earnings call will be held on May 4, 2017 During the earnings conference call's session XBiotech Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conference call the bridge access number and key in the PIN code, Contact XBiotech Inc for this information
Schedule a conference call with QCONF and get 5 free conference calls.
XBiotech is a clinical-stage biopharmaceutical company engaged in discovering and developing True Human(TM) monoclonal antibodies for treating a variety of diseases. True Human(TM) monoclonal antibodies are those which occur naturally in human beings--as opposed to being derived from animal immunization or otherwise engineered. We believe that naturally occurring monoclonal antibodies have the potential to be safer and more effective than their non-naturally occurring counterparts. While focused on bringing our lead product candidate to market, we also have developed a True Human(TM) pipeline and manufacturing system. The majority of our efforts to date have been concentrated on developing MABp1 (also known as Xilonix(TM), CA-18C3, CV-18C3, RA-18C3, and T2-18C3), a therapeutic antibody which specifically neutralizes interleukin-1 alpha (IL-1a). IL-1ais a pro-inflammatory protein produced by leukocytes and other cells, where it plays a key role in inflammation.Read more Conference Call